270 related articles for article (PubMed ID: 31884153)
21. MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy.
Frikha R; Elloumi M; Rebai T; Kamoun H
J Oncol Pharm Pract; 2022 Jul; 28(5):1031-1034. PubMed ID: 34000920
[TBL] [Abstract][Full Text] [Related]
22. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
Abdelaziz DH; Elhosseiny NM; Khaleel SA; Sabry NA; Attia AS; El-Sayed MH
Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
[TBL] [Abstract][Full Text] [Related]
23. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
25. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.
Kim NK; Chong SY; Jang MJ; Hong SH; Kim HS; Cho EK; Lee JA; Ahn MJ; Kim CS; Oh D
Anticancer Res; 2006; 26(4B):2879-81. PubMed ID: 16886608
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia.
Kamel AM; Moussa HS; Ebid GT; Bu RR; Bhatia KG
J Egypt Natl Canc Inst; 2007 Jun; 19(2):96-105. PubMed ID: 19034339
[TBL] [Abstract][Full Text] [Related]
28. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
29. MTHFR C677T and A1298C gene polymorphisms and their relation to homocysteine level in Egyptian children with congenital heart diseases.
Zidan HE; Rezk NA; Mohammed D
Gene; 2013 Oct; 529(1):119-24. PubMed ID: 23933414
[TBL] [Abstract][Full Text] [Related]
30. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
31. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.
Lin Z; Li Q; Sun Y; Huang J; Wang W; Fu J; Xu J; Zeng D
Lipids Health Dis; 2019 Jun; 18(1):143. PubMed ID: 31200713
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
[TBL] [Abstract][Full Text] [Related]
33. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.
Karathanasis NV; Stiakaki E; Goulielmos GN; Kalmanti M
Genet Test Mol Biomarkers; 2011; 15(1-2):5-10. PubMed ID: 21117954
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.
Salazar J; Altés A; del Río E; Estella J; Rives S; Tasso M; Navajas A; Molina J; Villa M; Vivanco JL; Torrent M; Baiget M; Badell I
Pharmacogenomics J; 2012 Oct; 12(5):379-85. PubMed ID: 21747412
[TBL] [Abstract][Full Text] [Related]
35. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
36. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
37. Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children.
Sadananda Adiga MN; Chandy S; Ramachandra N; Appaji L; Aruna Kumari BS; Ramaswamy G; Savithri HS; Krishnamoorthy L
Indian J Cancer; 2010; 47(1):40-5. PubMed ID: 20071789
[TBL] [Abstract][Full Text] [Related]
38. Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians.
Sood S; Das R; Trehan A; Ahluwalia J; Sachdeva MU; Varma N; Bansal D; Marwaha RK
Leuk Lymphoma; 2010 May; 51(5):928-32. PubMed ID: 20367562
[TBL] [Abstract][Full Text] [Related]
39. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults.
Zappacosta B; Graziano M; Persichilli S; Di Castelnuovo A; Mastroiacovo P; Iacoviello L
Cell Biochem Funct; 2014 Jan; 32(1):1-4. PubMed ID: 24277487
[TBL] [Abstract][Full Text] [Related]
40. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A
Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
